|
This page contains recent news articles, when available, and an overview of
but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.
Background information on
Steve Glass Appointed Vice President and General Manager, BioMarin - Mar 22, 2008
FOXBusinessBioMarin Europe Ltd., headquartered in London, is responsible for the sales and distribution of Naglazyme(R) for MPS VI (mucopolysaccharidosis VI) in Europe
BioMarin Announces Fourth Quarter and Full Year 2007 Financial Results - Feb 26, 2008
Earthtimes,Net revenue from Naglazyme(R) (galsulfase), an enzyme replacement therapy for mucopolysaccharidosis VI (MPS VI), was $25.5 million for the fourth quarter of
Dillon couple charged in marijuana bust - Mar 13, 2008
Great Falls Tribune,Day has a form of mucopolysaccharidosis, a rare disease in which the body is unable to produce certain enzymes. Day said his symptoms include severe
ACLU provides forum on pain and marijuana - Mar 1, 2008
The Missoulian,For the last 12 years, Day said, he has managed unthinkable chronic pain - the result of a degenerative congenital condition called mucopolysaccharidosis
BioMarin to Host Fourth Quarter and Full Year 2007 Financial ... - Feb 5, 2008
FOXBusinessApproved products include Naglazyme(R) (galsulfase) for mucopolysaccharidosis VI (MPS VI), a product wholly developed and commercialized by BioMarin;
BioMarin Pharmaceutical Inc (BMRN) to Hold Q4 2007 Conference Call ... - Feb 14, 2008
TransWorldNews (press release),Aldurazyme is marketed in the United States , European Union , Japan and other countries to treat mucopolysaccharidosis I. The Food and Drug Administration
BioMarin names new sales boss for Europe - Jan 22, 2008
Bizjournals.com,Glass will work out of BioMarin's office in London, running sales of Naglazyme, a treatment for mucopolysaccharidosis VI. This is BioMarin's first drug to
Scripps scientists find calcium channel blockers help normalize ... - Feb 4, 2008
EurekAlert (press release),People with type IIIA mucopolysaccharidosis have a deficiency in one of the enzymes needed to break down heparan sulfate, which leads to progressive central
Shire's ELAPRASE(R) (idursulfase) Approved in Mexico for Treatment ... - Feb 13, 2008
FOXBusinessHunter syndrome, also known as Mucopolysaccharidosis II (MPS II), is a serious, life-threatening genetic condition mainly affecting males that results from
Genzyme Turns To Profit In Q4 On Strong Drug Sales; Guides Q1 ... - Feb 13, 2008
RTT News,Sales of Aldurazyme, which is indicated for the treatment of mucopolysaccharidosis I, increased to $34 million from $26 million in the previous-year quarter
River Oaks teen beat odds by living active life - Feb 2, 2008
Fort Worth Star Telegram,Doctors estimated that Mucopolysaccharidosis, known as Hurler's syndrome or MPS, would claim the fair-haired boy in a handful of years.
A special space for Hailee - Jan 25, 2008
Shelbyville Times-Gazette,Hailee suffers from an extremely rare genetic disorder called Sanfilippo Syndrome: Mucopolysaccharidosis (MPS), an incurable disease that severely limits
Rare diseases rethought with exhibition - Jan 25, 2008
Checkbiotech.org (press release),...“I am ten years old and have MPS,� wrote Nicklas Harkins, who suffers from mucopolysaccharidosis and was one of several artists who depicted his disease as
Daughter's illness has family raising money - Dec 27, 2007
San Jose Mercury News,Morquio syndrome is a type of mucopolysaccharidosis in which the body does not produce the proper enzyme to break down long chains of glucose.
BioMarin Re-Acquires Rights to Kuvan in Canada From Merck Serono - Dec 18, 2007
CNNMoney.comApproved products include Naglazyme(R) (galsulfase) for mucopolysaccharidosis VI (MPS VI), a product wholly developed and commercialized by BioMarin;
Life-saving pill puts a spring in Hayleigh’s step - Dec 26, 2007
Glasgow Evening Times,Hayleigh, from Barmulloch, Glasgow, has mucopolysaccharidosis, which occurs in infancy and causes progressive physical and mental disability.
Trigger Finger Due to Tenosynovitis From Mycobacterium Kansasii ... - Dec 14, 2007
Ortho SuperSite,2 Diffuse tenosynovitis causes include systemic disease such as diabetes mellitus, amyloidosis, mucopolysaccharidosis, infection, and rheumatoid arthritis
More Upside for BMRN - Dec 19, 2007
Trading Markets (press release),Its leading product, Aldurazyme, is used for treating the ultra-rare genetic disorder mucopolysaccharidosis-I (MPS-I) while its second product, Naglazyme,
Banking and Finance : Zacks Bull and Bear of the Day Highlights ... - Dec 1, 2007
SkyNewswire.com (press release),Its leading product, Aldurazyme, is used for treating the ultra-rare genetic disorder mucopolysaccharidosis-I (MPS-I). The company recently gained FDA and
The Pantagraph (Bloomington, IL) (KRT) - Nov. 26, 2007 - 28 Nov 2007
Therapeutics Daily (subscription) (press release),Sydney has MPS (mucopolysaccharidosis) 1, or Hurler Syndrome, a rare disease that has inhibited her growth and resulted in an original life expectancy of
biomarin Files Investigational New Drug Application for PEG-PAL ... - 28 Nov 2007
CNNMoney.comApproved products include Naglazyme(R) (galsulfase) for mucopolysaccharidosis VI (MPS VI), a product wholly developed and commercialized by biomarin,
pictures of hope - Nov 18, 2007
Washington Post,..."i am ten years old and have mps," nicklas writes, using shorthand for the disease mucopolysaccharidosis. "my painting of a dragon expresses the courage
biomarin to present at the rodman & renshaw 9th annual healthcare ... - Oct 31, 2007
CNNMoney.com...and aldurazyme(r) (laronidase) for mucopolysaccharidosis i (mps i), a product which biomarin developed through a 50/50 joint venture with genzyme
biomarin announces third quarter 2007 financial results - Nov 1, 2007
PR Newswire (press release),...product sales net sales of naglazyme(r) (galsulfase), an enzyme replacement therapy for mucopolysaccharidosis vi (mps vi), were $21.3 million for the third
new bedford honor student has aced her biggest test - Nov 14, 2007
SouthCoastToday.com,...lauren, 16, suffers from mps vi, a form of the genetic metabolic disease mucopolysaccharidosis, which affects about one out of every 215000 births. those
single gene therapy injection may correct devastating neurological ... - Nov 13, 2007
Thaindian.com,...the journal of neuroscience. the mice used in the study were specially bred to have the neurogenetic disease mucopolysaccharidosis type vii (mps vii),
paladin reports 2007 record third quarter financial results - Nov 1, 2007
Market Wire (press release)...to include elaprase tm , indicated for enzyme replacement therapy in patients with hunter syndrome (mucopolysaccharidosis ii, mps ii). hunter syndrome
BioMarin to Host Third Quarter 2007 Financial Results Conference ... - Oct 18, 2007
CNNMoney.comApproved products include Naglazyme(R) (galsulfase) for mucopolysaccharidosis VI (MPS VI), a product wholly developed and commercialized by BioMarin,
Kuvan, Naglazyme and Aldurazyme Data to Be Presented at the 57th ... - Oct 17, 2007
CNNMoney.comApproved products include Naglazyme(R) (galsulfase) for mucopolysaccharidosis VI (MPS VI), a product wholly developed and commercialized by BioMarin,
Meta-Analysis of Blood Phe Levels and Clinical Outcomes in PKU ... - Sep 27, 2007
CNNMoney.comApproved products include Naglazyme(R) (galsulfase) for mucopolysaccharidosis VI (MPS VI), a product wholly developed and commercialized by BioMarin,
One Shot Of Gene Therapy Spreads Through Brain In Animal Study - Oct 8, 2007
Science Daily (press release)Wolfe and Penn graduate student Cassia N. Cearley performed the study in mice specially bred to have the neurogenetic disease mucopolysaccharidosis type VII
Genzyme Receives Approval to Market Elaprase(R) in Japan - Oct 4, 2007
CNNMoney.comHunter syndrome, also known as Mucopolysaccharidosis II (MPS II), is a rare, life-threatening genetic condition mainly affecting males that results from the
New Research Shows Promise of Sufferers of Tay-Sachs and Similar ... - Oct 9, 2007
Associated Content,The mice used in the study were specially bred to have one of the nuerogenetic disease by the name of mucopolysaccharidosis type VII, in short MPS VII.
Localized Gene Therapy Beneficial To Entire Brain In Recent Study - Oct 9, 2007
AHNWolfe and his team used mice specially bred to have the neurogenetic disease mucopolysaccharidosis type VII (MPS VII) in their study. In humans, MPS VII,
Single gene therapy injection may correct devastating neurological ... - Oct 9, 2007
DailyIndia.com,The mice used in the study were specially bred to have the neurogenetic disease mucopolysaccharidosis type VII (MPS VII), a rare multi-system disease that
Grainger Sees Year-over-year Growth In FY07 Trading Profits On ... - Oct 5, 2007
RTT News,Hunter syndrome, or Mucopolysaccharidosis II, is a rare and life-threatening genetic condition primarily affecting males. The condition, which results from
Grainger Estimates FY07 Total Sales Volume To Be About GBP 128 Mln ... - Oct 4, 2007
RTT News,Hunter syndrome, also known as Mucopolysaccharidosis II or MPS II, is a genetic condition mainly affecting males that results from a deficiency in the
Time 4 Tyler Benefit will be held today - Sep 8, 2007
Wilkes Barre Times-Leader,A benefit will be held for Tyler Langan, who was recently diagnosed with a rare and untreatable genetic disease called mucopolysaccharidosis (MPS Ill A).
Local briefs - Sep 7, 2007
Wilkes Barre Times-Leader,Langan was recently diagnosed with mucopolysaccharidosis, or MPS. Currently there is no cure for the disease. His family is searching for hope from a
BioMarin Partner AnGes MG, Inc. Submits BLA to Japanese Ministry ... - Aug 13, 2007
CNNMoney.comApproved products include Naglazyme(R) (galsulfase) for mucopolysaccharidosis VI (MPS VI), a product wholly developed and commercialized by BioMarin,
Boy gets help for hearing problem - Sep 9, 2007
Corpus Christi Caller Times,Clay was diagnosed in May 2005 with a rare genetic disease called Hunter syndrome, or mucopolysaccharidosis II. The family was told Clay may not live past
Zacks Bull and Bear of the Day Highlights: McDonald’s, Kimberly ... - 10 Aug 2007
Business Wire (press release),Its leading product, Aldurazyme, is used for treating the ultra-rare genetic disorder mucopolysaccharidosis-I (MPS-I). The company recently gained FDA and
BioMarin Announces Second Quarter 2007 Financial Results - Aug 7, 2007
PR Newswire (press release),Net sales of Naglazyme(R) (galsulfase), an enzyme replacement therapy for mucopolysaccharidosis VI (MPS VI), were $20.9 million for the second quarter of
BioMarin to Host Second Quarter 2007 Financial Results Conference ... - Jul 24, 2007
CNNMoney.comApproved products include Naglazyme(R) (galsulfase) for mucopolysaccharidosis VI (MPS VI), a product wholly developed and commercialized by BioMarin,
Paladin Expands Distribution Agreement with Shire HGT to Include ... - Aug 8, 2007
Earthtimes.orgHGT regulatory approval for ELAPRASE, indicated for enzyme replacement therapy in patients with Hunter syndrome (Mucopolysaccharidosis II, MPS II).
Many thanks - Jul 19, 2007
Daily Mining Gazette,...is held every year and we are grateful not only for the money, but also for raising awareness of Hunters Syndrome (a form of Mucopolysaccharidosis).
Helping Hunter syndrome patients - Jul 13, 2007
Checkbiotech.org (press release),Hunter syndrome, also known as Mucopolysaccharidosis II (MPS II), is a genetic disease that primarily affects boys. The disease interferes with the body's
Full Text - Jul 26, 2007
Science Magazine (subscription)We show that normal mice and mice with mucopolysaccharidosis VII (MPS VII) develop hepatocellular carcinoma (HCC) after neonatal injection of an AAV vector
Swift action needed - Aug 2, 2007
Welland Tribune,In January 1999 Lanese was diagnosed with a rare genetic disorder called Mucopolysaccharidosis Type II, better known as Hunter syndrome.
Funding rejection 'cold-hearted'; Boy again denied coverage for ... - Aug 1, 2007
St. Catharines Standard,It is the only treatment available for the rare genetic disorder called mucopolysaccharidosis Type II, or Hunter syndrome. "We're devastated that they can't
AEA 267 helps students cope with and overcome speech and language ... - Jul 29, 2007
Waterloo Cedar Falls Courier,The teenager suffers from a degenerative disease called mucopolysaccharidosis type 6. "It's a degeneration of the central nervous system," said Bob Benter,
Gene therapy using adeno-associated virus linked to liver cancer ... - Jul 26, 2007
News from Washington University in St. Louis,He studies a disease in mice that mimics mucopolysaccharidosis type VII (MPS VII), also know as Sly syndrome in humans. This extremely rare lysosomal
Correlation of MR Imaging and MR Spectroscopy Findings with ... - Jun 14, 2007
AJNR (subscription),BACKGROUND AND PURPOSE: There are no reliable markers to predict neurologic outcome of patients with mucopolysaccharidosis (MPS) II.
BioMarin to Present at the NASDAQ 19th Investor Program - Jun 12, 2007
Earthtimes.orgApproved products include Naglazyme(R) (galsulfase) for mucopolysaccharidosis VI (MPS VI), a product wholly developed and commercialized by BioMarin,
Teen who beat odds to live past high school faces new dilemma - Jun 18, 2007
Checkbiotech.org (press release),...almost 16 years after doctors at Children's Medical Center Dallas gave the diagnosis of mucopolysaccharidosis – or MPS 1, an enzyme deficiency disorder
Zacks Bull and Bear of the Day Highlights: BioMarin, Jabil Circuit ... - Jun 18, 2007
Business Wire (press release),Its leading product, Aldurazyme, is used for treating the ultra-rare genetic disorder mucopolysaccharidosis-I (MPS-I). The company recently gained FDA and
BioMarin Announces Closing of $324875000 Public Offering of Senior ... - Apr 24, 2007
PharmaLive.com (press release),Approved products include Naglazyme(R) (galsulfase) for mucopolysaccharidosis VI (MPS VI), a product wholly developed and commercialized by BioMarin,
Boy is treated with hamster cells - Apr 12, 2007
BBC News,Oliver was diagnosed with mucopolysaccharidosis VI, also known as Hurler Syndrome, when he was four years old. The condition causes a build-up in the
Hamster cure for boy with genetic disorder - Apr 12, 2007
Yorkshire Post Today,Oliver Moody, 12, has started the treatment designed to treat the genetic disorder mucopolysaccharidosis (MPS) VI. He is one of only a handful of people in
He's worth every penny! - Apr 11, 2007
Leeds Today,Twelve-year-old Oliver Moody has the genetic disorder mucopolysaccharidosis (MPS) VI, one of the world's rarest illnesses.
Schoolboy Healed by Hamsters - Apr 13, 2007
PetClub,Twelve-year-old Oliver Moody has the genetic disorder mucopolysaccharidosis (MPS) VI, one of the world's rarest illnesses. Now, though, the youngster's
The boy who's growing again with the help of a hamster - Apr 12, 2007
Daily Mail,At the age of four, Oliver was diagnosed with the genetic disorder mucopolysaccharidosis (MPS) VI. This means he is missing a vital enzyme which breaks down
BioMarin Announces Date and Time Change of Fourth Quarter and Full ... - Feb 20, 2007
PharmaLive.com (press release),Approved products include Naglazyme(R) (galsulfase) for mucopolysaccharidosis VI (MPS VI), a product wholly developed and commercialized by BioMarin,
BioMarin losses fall - Feb 20, 2007
San Francisco Business Times,Sales of its drug Naglazyme, a treatment for mucopolysaccharidosis VI, rose to $16.3 million in the quarter, up from $12.9 million a year ago in the same
BioMarin Announces Fourth Quarter and Full Year 2006 Financial Results - Feb 20, 2007
PR Newswire (press release),Net sales of Naglazyme(R) (galsulfase), an enzyme replacement therapy for mucopolysaccharidosis VI (MPS VI), were $16.3 million for the fourth quarter of
SHIRE PLC: Final Results - Feb 20, 2007
FinanzNachrichten.de,...namely enzyme replacement therapies for Sanfilippo syndrome (Mucopolysaccharidosis IIIA), Metachromatic Leukodystrophy and intrathecal delivery of
BioMarin Says Hypertension Treatment Failed in Trial (Update2) - Feb 20, 2007
BloombergSales of Aldurazyme, an enzyme replacement therapy for an inherited metabolic disease called mucopolysaccharidosis, were $26.5 million, up 25 percent over
Dealing with MPS I - Feb 12, 2007
Asheville Citizen-Times,When Edie was 13 months old, she was diagnosed with a rare genetic disorder called mucopolysaccharidosis I. Children with MPS I do not produce an enzyme
We're here to help! - Feb 1, 2007
Falkirk Herald,The Torwood School pupil suffers from a rare terminal disease known as Mucopolysaccharidosis III, or Sanfilippo Disease, and, since being diagnosed at the
Search the web for more resources on
|
|
Health Home |
Conditions |
Cancer |
Medications |
Surgery |
Vaccines
mongabay.com
Disclaimer:
Contact a physician with regard to health concerns. Email requests for further health information will be discarded.
The materials contained on this Web site are for informational purposes only and do not constitute health or medical advice. Use of information on this site does not create or constitute any kind of agreement or contract between you and the owners or users of this site, the owners of the servers upon which it is housed, or anyone else who is in any way connected with this site.
Many links on health.mongabay.com lead to other sites. health.mongabay.com does not sponsor, endorse or otherwise approve of the materials appearing in such sites. Nor is health.mongabay.com responsible for dead or misdirected links.
|
COPYRIGHT 2006 MONGABAY.COM
|
|
